TPFS, resulting from a heterozygous mutation in the PCGF2 gene on chromosome 17q12, is associated with a spectrum of developmental abnormalities; however, epilepsy has not been well documented as a feature of this condition. This evidence concerns the gene PCGF2 and epilepsy.